InsiderClue
← All stocks

Nautilus Biotechnology, Inc.

NAUT Net selling
CIK 0001808805 #4256 in the set updated 17 Sep 2026
Bought (12 mo)
$71.20K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$11.75M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$11.75M
2 of 2 sales
Net
−$11.68M
−$11.68M against sales at will

By person

7 insiders · 4 transactions
45.5×

Sujal Patel holds 45.5 times base salary in stock. $24.36M of shares against $535.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Sujal Patel last reported holding, valued at $2.35, the price Common Stock was last bought or sold at on the open market here, on 2 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
AH Equity Partners Bio II, L.L.C. entity
10% owner
—
$11.75M (2)
−$11.75M
971,885
0.7637%
$2.28M
−83.7%
Patel Sujal M
CEO, President, and Secretary
$65.24K (1)
—
+$65.24K
10,366,721
8.15%
$24.36M
+3.0%
Suzuki Kentaro
Chief Marketing Officer
$5.96K (1)
—
+$5.96K
4,000
0.0031%
$9.40K
—
Mallick Parag
Chief Scientist
—
—
—
20,493,392
16.10%
$48.16M
+0.1%
Mowry Anna
CFO and Treasurer
—
—
—
83,000
0.0652%
$195.05K
+22.1%
Murphy Matthew B.
General Counsel
—
—
—
74,140
0.0583%
$174.23K
+36.9%
Godwin Mary E.
Senior VP, Operations
—
—
—
0
0.0000%
$0.00
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
AH Equity Partners Bio II, L.L.C.
2 Jun 2026
10% owner
Sell indirect
384,026
$2.35
$902.46K
AH Equity Partners Bio II, L.L.C.
2 Jun 2026
10% owner
Sell indirect
4,615,974
$2.35
$10.85M
Show all 4 transactions →

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 0
History held since 11 Aug 2020